This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dr. Daniel Soffer, MD Is Recognized By Continental Who's Who As A Pinnacle Professional In The Field Of Medicine

NEW YORK, April 4, 2013 /PRNewswire/ -- /Continental Who's Who/ -- Dr. Daniel Soffer, MD is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as a Cardiologist with Mount Sinai Medical Center.

In his current role, Dr. Soffer's areas of expertise include percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke, atrial septal defect (ASD) closure, and percutaneous balloon valvuloplasty of the aortic and mitral valves. In addition, Dr. Soffer specializes in high risk coronary interventions and carotid stenting as well as limb salvage procedures using thrombectomy and all atherectomy devices available in the United States. He also has an abiding interest in reno-vascular disease and refractory hypertension, in particular renal artery stenosis, and performs percutaneous interventions to treat these disorders. Furthermore, Dr. Soffer's interests extend into the field of research and development. In this capacity, he has served as a co-investigator in numerous clinical trials assessing new techniques and devices in the coronary, carotid and peripheral circulation as well as structural heart disease.

Prior to his position with Mount Sinai Medical Center, Dr. Soffer spent 7 years at Lenox Hill Hospital where he worked with his mentor, Dr. Gary Roubin, as a member of the interventional coronary, peripheral and structural heart teams. Dr Soffer trained at the world renowned William Beaumont Hospital in Royal Oak, Michigan with Drs. William O'Neill, Cindy Grines and Robert Safian followed by two year tenure in North Carolina where he stamped his expertise in cardiac, carotid and peripheral interventions. He completed his residency and his cardiology fellowship programs at Lenox Hill Hospital and he is currently board certified in Cardiovascular Disease, Interventional Cardiology and Endovascular Medicine.

As a result of his vast accomplishments in the field of Medicine, Dr. Soffer has been named as a Top Physician in Interventional Cardiology, and is also a Two-Time Recipient of the Swiss Foundation Scholarship. In addition, in 1990 he was selected as an Honorary Student in the Cardiology and Emergency Medicine Department of Albert Einstein College of Medicine. Furthermore, in 1989 he was recognized as a visiting Honorary Student in Cardiothoracic Surgery at Uelleval Hospital in Oslo, Norway.

Dr. Soffer earned his Medical Degree at Ben Gurion University of the Negev and is a member of the American Board of Internal Medicine and Fellow of the American College of Cardiology and The Society for Cardiac Angiography and Interventions.

About UsContinental Who's Who has become one of the most respected and trusted publishers around the globe.  We spotlight thousands of professional individuals and organizations each year who "stand-out" in their specific field.  Included are executives and officials in business, science, education, philanthropy, religion, government, the fourth estate, finance, law, engineering, authors, the musically talented elite as well as numerous additional industries.

Our mission at Continental Who's Who is to provide an exclusive internationally recognized world-class forum where members can create social, professional and business relationships.  We provide resources, information and represent an atmosphere and opportunity to network, consult, showcase, educate, and empower, allowing for establishing new business relations to increase future success.  We are committed to delivering the highest quality service to all our established members.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs